Treatment patterns of castration-resistant prostate cancer: A retrospective claims database analysis

被引：0
|
作者：
Burton, Tanya
Teitelbaum, April H.
Bui, Cat N.
Spalding, James Robert
机构：
[1] OptumInsight, Waltham, MA USA
[2] OptumInsight, San Diego, CA USA
[3] Astellas Pharma US Inc, Northbrook, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 34期
关键词：
D O I：
10.1200/jco.2012.30.34_suppl.198
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
198
引用
收藏
页数：1
相关论文
共 50 条
  • [41] New treatment options for castration-resistant prostate cancer
    Simondsen, Katherine
    Kolesar, Jill
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2013, 70 (10) : 856 - 865
  • [42] Castration-Resistant Prostate Cancer: Mechanisms, Targets and Treatment
    Mansinho, Andre
    Macedo, Daniela
    Fernandes, Isabel
    Costa, Luis
    MOLECULAR & DIAGNOSTIC IMAGING IN PROSTATE CANCER: CLINICAL APPLICATIONS AND TREATMENT STRATEGIES, 2019, 1126 : 117 - 133
  • [43] Enzalutamide for the treatment of nonmetastatic castration-resistant prostate cancer
    Altavilla, Amelia
    Casadei, Chiara
    Lolli, Cristian
    Menna, Cecilia
    Ravaglia, Giorgia
    Gurioli, Giorgia
    Farolfi, Alberto
    Brighi, Nicole
    Conteduca, Vincenza
    Burgio, Salvatore Luca
    Schepisi, Giuseppe
    Rossi, Lorena
    Gargiulo, Stefania
    Lisotti, Ivana
    De Giorgi, Ugo
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (17) : 2091 - 2099
  • [44] Targeting treatment options for castration-resistant prostate cancer
    Miller, Dannah R.
    Ingersoll, Matthew A.
    Teply, Benjamin A.
    Lin, Ming-Fong
    AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2021, 9 (01): : 101 - 120
  • [45] Enzalutamide for the treatment of metastatic castration-resistant prostate cancer
    Rodriguez-Vida, Alejo
    Galazi, Myria
    Rudman, Sarah
    Chowdhury, Simon
    Sternberg, Cora N.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 3325 - 3339
  • [46] Perspectives on Treatment of Metastatic Castration-Resistant Prostate Cancer
    Merseburger, Axel S.
    Bellmunt, Joaquim
    Jenkins, Cheryl
    Parker, Chris
    Fitzpatrick, John M.
    ONCOLOGIST, 2013, 18 (05): : 558 - 567
  • [47] DISEASE SPECIFIC COST ANALYSIS OF THE NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER AND METASTATIC CASTRATION-RESISTANT PROSTATE CANCER HEALTH STATES
    Yanev, I
    Aprikian, A.
    Nablsi, E.
    Primiani, J.
    Vaillancourt, Z.
    Dragomir, A.
    VALUE IN HEALTH, 2018, 21 : S73 - S73
  • [48] Treatment patterns and outcomes in patients with nonmetastatic castration-resistant prostate cancer in the United States
    Swami, Umang
    Hong, Agnes
    Diessner, Brandon
    Young, Christopher
    Bunner, Scott H.
    Xie, Bin
    Ramaswamy, Krishnan
    Chastek, Benjamin
    El Chaar, Nader
    Gupta, Sumati
    FUTURE ONCOLOGY, 2024, 20 (32) : 2467 - 2480
  • [49] Abiraterone acetate, enzalutamide and their sequence for castration-resistant prostate cancerAdherence, survival and hospitalization analysis of a medical claims database
    Badereddin Mohamad Al-Ali
    Klaus Eredics
    Stephan Madersbacher
    Ingrid Schauer
    Wiener klinische Wochenschrift, 2018, 130 : 659 - 664
  • [50] Carbon Ion Radiation Therapy for Nonmetastatic Castration-Resistant Prostate Cancer: A Retrospective Analysis
    Miyasaka, Yuhei
    Kawamura, Hidemasa
    Sato, Hiro
    Kubo, Nobuteru
    Katoh, Hiroyuki
    Ishikawa, Hitoshi
    Matsui, Hiroshi
    Miyazawa, Yoshiyuki
    Ito, Kazuto
    Suzuki, Kazuhiro
    Ohno, Tatsuya
    ADVANCES IN RADIATION ONCOLOGY, 2024, 9 (04)
12345